196 related articles for article (PubMed ID: 18389443)
1. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
[TBL] [Abstract][Full Text] [Related]
2. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
[TBL] [Abstract][Full Text] [Related]
3. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
4. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
5. Does complement kill E. coli by producing transmural pores?
Born J; Bhakdi S
Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981
[TBL] [Abstract][Full Text] [Related]
6. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
Ben Nasr A; Klimpel GR
J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
[TBL] [Abstract][Full Text] [Related]
7. Quantification of complement C5b-9 binding to cells by flow cytometry.
Moskovich O; Fishelson Z
Methods Mol Biol; 2014; 1100():103-8. PubMed ID: 24218253
[TBL] [Abstract][Full Text] [Related]
8. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
Betz SJ; Page N; Estrade C; Isliker H
J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
10. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism.
Taylor PW
Exp Clin Immunogenet; 1992; 9(1):48-56. PubMed ID: 1642903
[TBL] [Abstract][Full Text] [Related]
12. Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7.
Doorduijn DJ; Bardoel BW; Heesterbeek DAC; Ruyken M; Benn G; Parsons ES; Hoogenboom BW; Rooijakkers SHM
PLoS Pathog; 2020 Jun; 16(6):e1008606. PubMed ID: 32569291
[TBL] [Abstract][Full Text] [Related]
13. The complement system. Activation, modulation, and clinical relevance.
Lim HW
Dermatol Clin; 1990 Oct; 8(4):609-18. PubMed ID: 2249355
[TBL] [Abstract][Full Text] [Related]
14. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
Preissner KT; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
Dankert JR
J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
[TBL] [Abstract][Full Text] [Related]
17. Distinct localization of the complement C5b-9 complex on Gram-positive bacteria.
Berends ET; Dekkers JF; Nijland R; Kuipers A; Soppe JA; van Strijp JA; Rooijakkers SH
Cell Microbiol; 2013 Dec; 15(12):1955-68. PubMed ID: 23869880
[TBL] [Abstract][Full Text] [Related]
18. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
Pedersen ED; Aass HC; Rootwelt T; Fung M; Lambris JD; Mollnes TE
Scand J Immunol; 2007; 66(2-3):345-51. PubMed ID: 17635812
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
[TBL] [Abstract][Full Text] [Related]
20. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.
Gerl VB; Bohl J; Pitz S; Stoffelns B; Pfeiffer N; Bhakdi S
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1104-8. PubMed ID: 11923252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
